Acute responses of inflammatory markers of cardiovascular disease risk to a single walking session

Journal of Physical Activity and Health

Volumn 2, Issue 3, 2005, Pages 324-332

  Murtagh, Elaine M ^a   Boreham, Colin ^a   Nevill, Alan ^b   Davison, Gareth ^a   Trinick, Tom ^c   Duly, Ellie ^c   El Agnaf, Mawloud ^c   Murphy, Marie H ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^c ULSTER HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Exercise; Health; Interleukin 6

Indexed keywords

EID: 37349060779     PISSN: 15433080     EISSN: 15435474     Source Type: Journal    
DOI: 10.1123/jpah.2.3.324     Document Type: Article

References (39)

1. Raifai N, Ridker PA. High-sensitivity C-reactive protein: a novel and promising marker for coronary heart disease. Clin Chem. 2001;47:403-411.
2. Libby P, Ridker PA, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105: 1135-1143.
3. Koenig W, Sund M, Frohlich ED. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men—results from the MONICA Augsburg Cohort study, 1984 to 1992. Circulation. 1999;99:237-242.
4. Yudkin J, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
5. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101(15):1767-1772.
6. Volpato S, Guralnik JM, Ferrucci L. Cardiovascular disease, interleukin-6 and risk of future myocardial infarction among apparently healthy men. Circulation. 2001;103: 947-953.
7. Magliano DJ, Liew D, Ashton EL, Sundararajan V, McNeil JJ. Novel biomedical risk markers for cardiovascular disease. J Cardiovasc Risk. 2003;10:41-55.
8. Haskell WL. Health consequences of physical activity: understanding and challenges regarding dose-response. Med Sci Sport Exerc. 1994;26(6):649-660.
9. Suzuki I, Yamada H, Sugiura T, Kawakami N, Shimizu H. Cardiovascular fitness, physical activity and selected coronary heart disease risk factors in adults. J Sports Med Phys Fitness. 1998;38(2):149-157.
10. Yamada M, Suzuki K, Kudo S. Raised plasma G-Csf and Il-6 after exercise may play a role in neutrophil responses. J Appl Physiol. 2002;92:1789-1794.
11. Willoughby DS, McFarlin B, Bois C. Interleukin-6 expression after repeated bouts of eccentric exercise. Int J Sports Med. 2003;24:15-21.
12. Meyer T, Gabriel H, Ratz M. Anaerobic exercise induces moderate acute phase response. Med Sci Sport Exerc. 2001;33:549-555.
13. Dufaux B, Order U, Hollman W. Serum C-Reactive protein and immune-complexes after exercise and training. Int J Sports Med. 1983;4:69.
14. Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW, Blair SN. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness— a randomized trial. JAMA. 1999;281(4):327-334.
15. Murtagh EM, Boreham CAG, Murphy MH. Speed and exercise intensity of recreational walkers. Prev Med. 2002;35(4):397-400.
16. Fiotti N, Giansante C, Ponte E, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 1999;145(1):51-60.
17. Signorelli SS, Mazzarino MC, DiPino L. High circulating levels of cytokines (Il-6 and Tnf Alpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med. 2003;8:15-19.
18. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health—a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273(5):402-407.
19. Altman DG. Statistics and ethics in medical research: III How large a sample size. Brit Med J. 1980;281:1336-1338.
20. Jones PRM, Hunt MJ, Brown TP, Norgan NG. Waist-hip circumference ratio and its relation to age and overweight in British men. Hum Nutr: Clin Nutr. 1986;40C:239-247.
21. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription. 6th ed. Baltimore: Lippincott Williams and Wilkins; 2000.
22. Ridker PM. Clinical application of c-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(363-369).
23. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sport Exerc. 1982;14(5):377-381.
24. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sport Exerc. 2000;32(9, Suppl.): 498-516.
25. Dacie JV, Lewis SM. Practical haematology. London: Churchill; 1968.
26. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol. 1974;37(2):247-248.
27. Donato KA, Pi-Sunyer FX, Becker DM, et al. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Int Med. 1998;158(17):1855-1867.
28. Rawson ES, Freedson PS, Osganian SK. Body mass index, but not physical activity, is associated with c-reactive protein. Med Sci Sport Exerc. 2003;35:1160-1166.
29. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105(7):804-809.
30. US Dept of Health and Human Services. The Surgeon General’s call to action to prevent and decease overweight and obesity. Washington: US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2001.
31. Pedersen BK, Toft AD. Effects of exercise on lymphocytes and cytokines. Brit J Sports Med. 2000;34:246-251.
32. Ronsen O, Lea T, Bahr R. Enhanced plasma IL-6 and Il-1ra responses to repeated vs single bouts of prolonged cycling in elite athletes. J Appl Physiol. 2002;92:2547-2553.
33. Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med. 2001;31(2):115-144.
34. Cannon JG. Exercise and the acute phase response. In: Hoffman-Goetz L, ed. Exercise and immune function. New York: CRC Press; 1996.
35. Biasucci LM, Liuzzo G, Fantuzzi G. Increasing levels of interleukin (Il)-1ra and Il-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk on in-hospital coronary events. Circulation. 1999;99:2079-2084.
36. Hubinger L, Mackinnon LT, Barber L, McCosker J, Howard A, Lepre F. Acute effects of treadmill running on lipoprotein(a) levels in males and females. Med Sci Sport Exerc. 1997;29(4):436-442.
37. Fallon KE, Fallon SK, Boston T. The acute phase response and exercise: court and field sports. Brit J Sports Med. 2001;35(3):170-173.
38. Nosaka K, Clarkson PM. Changes in indicators of inflammation after eccentric exercise of the elbow flexors. Med Sci Sport Exerc. 1996;28:953-961.
39. Gabay C, Kushner I. Mechanisms of disease: acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454.